CrizotinibDevelopment of resistance in lung adenocarcinoma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1539卷 / 1期

关键词：

D O I：

10.1007/s40278-015-7663-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：108 / 108

相关论文

共 50 条

[21] CrizotinibDevelopment of crizotinib resistance: case report.
[J]. Reactions Weekly, 2020, 1820 (1) : 113 - 113
[22] CrizotinibDevelopment of resistance with gene mutation: case report
[J]. Reactions Weekly, 2019, 1770 (1) : 131 - 131
[23] Alectinib/crizotinibDevelopment of drug resistance: case report
[J]. Reactions Weekly, 2016, 1615 (1) : 16 - 16
[24] Brentuximab vedotin/crizotinibDevelopment of resistance: case report
[J]. Reactions Weekly, 2016, 1600 (1) : 59 - 59
[25] CrizotinibDevelopment of resistance with gene mutation: case report
[J]. Reactions Weekly, 2018, 1699 (1) : 79 - 79
[26] Ceritinib/crizotinibDevelopment of drug resistance: case report
[J]. Reactions Weekly, 2017, 1633 (1) : 178 - 178
[27] CrizotinibDevelopment of drug resistance in non-small cell lung cancer: case report
[J]. Reactions Weekly, 2018, 1733 (1) : 121 - 121
[28] Alectinib/crizotinibDevelopment of resistance in non-small cell lung cancer: case report
[J]. Reactions Weekly, 2016, 1616 (1) : 15 - 15
[29] AntineoplasticsAcquired resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2020, 1828 (1) : 64 - 64
[30] ErlotinibAcquired resistance in lung adenocarcinoma: case report
[J]. Reactions Weekly, 2017, 1682 (1) : 134 - 134

← 1 2 3 4 5 →